Lumito AB (publ) (NGM:LUMITO)

Market Cap	4.15M -93.2%
Revenue (ttm)	78.00K +107.0%
Net Income	-41.42M
EPS	-11.79
Shares Out	3.51M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,228
Open	n/a
Previous Close	1.270
Day's Range	n/a
52-Week Range	1.182 - 120.000
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Lumito AB

Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden. The company offers SCIZYS Erbium Kit, an upconverting nanoparticle (UCNP) based IHC kit that enables the identification of biotinylated primary or secondary antibodies in histological samples; SCIZYS S1, a whole slide imaging scanner that images histological samples using brightfield and UCNPs to display both chromogenic counterstaining and UCNP luminescence; and Katana Viewer, the file output format from SCIZYS, OME-TIFF can be used with any softw...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2010
• Employees: 7
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: LUMITO

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 10, 2026

Data Sources Report a data error